SUPER-REFRACTORY STATUS EPILEPTICUS
Clinical trials for SUPER-REFRACTORY STATUS EPILEPTICUS explained in plain language.
Never miss a new study
Get alerted when new SUPER-REFRACTORY STATUS EPILEPTICUS trials appear
Sign up with your email to follow new studies for SUPER-REFRACTORY STATUS EPILEPTICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug tested for most dangerous seizures
Disease control CompletedThis study tested an experimental drug called SAGE-547 for people with super-refractory status epilepticus, a life-threatening condition where seizures do not stop despite multiple medications. The goal was to see if adding SAGE-547 to standard care was safe and could help contro…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE1, PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:56 UTC
-
Experimental drug tested to stop dangerous, unending seizures
Disease control CompletedThis study tested whether an experimental drug called SAGE-547 could help patients with a severe, life-threatening form of continuous seizures that does not respond to standard medications. The trial involved 132 patients who were already in intensive care and receiving strong an…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC